
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The race is on to turn your body into a GLP-1 factory - 2
Virtual reality opens doors for older people to build closer connections in real life - 3
Medical team successfully delivers baby and removes massive tumor - 4
A Manual for Extravagant Vehicles Available in 2024 - 5
Brazil's former President Jair Bolsonaro seeks house arrest for prison time citing health issues
This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
Find Successful Magnificence Items for Sparkling Skin
10 Natural products to Remember for Your Eating routine for a Better You
Three arrested in Paris after attempted bomb attack outside Bank of America
How a seabird native to Hawaii has adapted to life in Honolulu's concrete jungle
Nearly 16,000 New York City nurses prepare to strike as contract talks stall
Top notch Remote Earphones for Audiophiles
The Delight of Camper Vans: Choosing the One That Meets Your Requirements
Russia earning billions from Hormuz blockade, German trade body says













